Policy & Regulation
18 March 2024 - Biopharmaceutical company Bristol Myers Squibb (BMS) (NYSE:BMY) confirmed on Monday that it has completed its acquisition of biopharmaceutical company Karuna Therapeutics Inc (Nasdaq:K...
18 March 2024 - Clinical-stage biopharmaceutical company Faron Pharmaceuticals Ltd (AIM: FARN) (First North: FARON) shares additional positive data from the Phase 1 part of the BEXMAB trial, showcasin...
18 March 2024 - Biopharmaceutical company GSK plc (LSE/NYSE: GSK) on Monday revealed significant overall survival (OS) data from RUBY phase III trial, indicating the potential of Jemperli (dostarlimab...
18 March 2024 - Mathematical modelling and data science company Physiomics plc (AIM: PYC) announced on Monday that it has been awarded a significant contract by an existing pharma client, valued at GB...
18 March 2024 - ImmVira, a biotechnology company focused on developing and synthesising a biological vector delivery platform, announced on Friday that it has received Fast Track designation from the ...
15 March 2024 - Gilgamesh Pharmaceuticals, a clinical-stage neuroscience company, announced on Thursday that it has received a multi-year USD14m grant from National Institute on Drug Abuse (NIDA).The ...